Abstract
Benign prostatic hyperplasia (BPH) is a prevalent condition among middle-aged and elderly men, often causing lower urinary tract symptoms (LUTS). Current treatment options encompass watchful waiting, pharmacological therapy, and surgical intervention. Among these, surgical treatment rapidly alleviates LUTS and enhances quality of life, making it the most effective approach for moderate to severe BPH. In recent years, with the rapid development and clinical application of various laser technologies, transurethral resection of the prostate (TURP), once considered the "gold standard," has faced controversies due to its higher surgical morbidity and limitations in treating large prostate volumes. Laser technologies, with their remarkable surgical efficacy, safety, and reduced morbidity, have increasingly gained favor among clinicians. This article primarily delves into the clinical advancements of diode laser minimally invasive technology in BPH treatment, aiming to provide a theoretical basis for clinicians in addressing clinical challenges.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
